{"filing":{"accession_number":"0001104659-26-110207","cik":"0001867729","ticker":"WRDIF","company_name":"WeRide Inc.","form":"6-K","filing_date":"2026-09-24","report_date":"2026-09-24","primary_document":"tm2625999d1_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1867729/000110465926110207/tm2625999d1_6k.htm"},"events":[{"id":34740,"run_id":31986,"accession_number":"0001104659-26-110207","anchor_item_number":"EX-99.1","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"This announcement discloses the grant of 17,880,200 Restricted Share Units to executives and employees under the 2026 Share Plan on September 23, 2026. The grant includes 493,434 RSUs each to Dr. Han (CEO/founder) and Dr. Li (CTO/co-founder), plus 16,893,332 RSUs to 158 employees and senior management. The disclosure details vesting schedules (36 months for executives with performance-based conditions, 23-45 months for other employees), performance targets linked to revenue, and clawback mechanisms—all hallmarks of executive compensation arrangements. This is a material equity incentive grant to named executives and senior management that would affect investor assessment of compensation practices and dilution.","company_name":"WeRide Inc.","ticker":"WRDIF","filing_date":"2026-09-24","form":"6-K","submitted_at":null,"items":[{"id":38569,"accession_number":"0001104659-26-110207","item_number":"EX-99.1","item_title":"tm2625999d1_ex99-1.htm","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This announcement discloses the grant of 17,880,200 Restricted Share Units to executives and employees under the 2026 Share Plan on September 23, 2026. The grant includes 493,434 RSUs each to Dr. Han (CEO/founder) and Dr. Li (CTO/co-founder), plus 16,893,332 RSUs to 158 employees and senior management. The disclosure details vesting schedules (36 months for executives with performance-based conditions, 23-45 months for other employees), performance targets linked to revenue, and clawback mechanisms—all hallmarks of executive compensation arrangements. This is a material equity incentive grant to named executives and senior management that would affect investor assessment of compensation practices and dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-24T13:01:52.108048+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":38569,"accession_number":"0001104659-26-110207","item_number":"EX-99.1","item_title":"tm2625999d1_ex99-1.htm","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This announcement discloses the grant of 17,880,200 Restricted Share Units to executives and employees under the 2026 Share Plan on September 23, 2026. The grant includes 493,434 RSUs each to Dr. Han (CEO/founder) and Dr. Li (CTO/co-founder), plus 16,893,332 RSUs to 158 employees and senior management. The disclosure details vesting schedules (36 months for executives with performance-based conditions, 23-45 months for other employees), performance targets linked to revenue, and clawback mechanisms—all hallmarks of executive compensation arrangements. This is a material equity incentive grant to named executives and senior management that would affect investor assessment of compensation practices and dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-24T13:01:52.108048+00:00","company_name":"WeRide Inc.","ticker":"WRDIF","filing_date":"2026-09-24"}]}